Times to pain relief and pain freedom with rizatriptan 10 mg and other oral triptans.

Times to pain relief and pain freedom with rizatriptan 10 mg and other oral triptans. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Times to pain relief and pain freedom with rizatriptan 10 mg and other oral triptans. Abstract Text:

D S Ng-Mak,X H Hu,Y Chen,L Ma,G Solomon,D S Ng-Mak,X H Hu,Y Chen,L Ma,G Solomon,

BACKGROUND: In the clinical trial setting, oral rizatriptan 10 mg has greater efficacy than other oral triptans in freedom from migraine headache pain 2 h after dosing. OBJECTIVE: The study objective is to compare the effectiveness of rizatriptan 10 mg and other oral triptans for acute migraine attack in a naturalistic setting. METHODS: A total of 673 patients took rizatriptan 10 mg or their usual-care oral triptans for two migraine attacks in a sequential, cross-over manner and recorded outcomes using a diary and a stopwatch. Mean and median times to pain relief (PR) and pain freedom (PF) for rizatriptan and other oral triptans were compared. The effect of rizatriptan on times to PR and PF, adjusting for potential confounding factors (treatment sequence, treatment order and use of rescue medication), was computed via a Cox proportional hazard model. RESULTS: Significantly, more patients taking rizatriptan achieved both PR and PF within 2 h after dosing than other oral triptans. Times to PR and PF were shorter with rizatriptan than with other oral triptans (median time to PR: 45 vs. 52 min, p < 0.0001; median time to PF: 100 vs. 124 min, p < 0.0001). The adjusted proportional hazard ratios (rizatriptan vs. other oral triptans) for times to PR and PF were 1.32 (95% CI: 1.22-1.44) and 1.27 (95% CI: 1.16-1.39) respectively. CONCLUSION: The times to PR and PF in a 'naturalistic' setting were significantly shorter for patients treating a migraine attack with rizatriptan 10 mg than with other oral triptans.

Times to pain relief and pain freedom with rizatriptan 10 mg and other oral triptans. Publishing Authors By Initials

DS Ng-Mak,XH Hu,Y Chen,L Ma,G Solomon,DS Ng-Mak,XH Hu,Y Chen,L Ma,G Solomon,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Times to pain relief and pain freedom with rizatriptan 10 mg and other oral triptans. Journal Published:

PUBLICATION TYPE: Research Support, Non-U.S. Gov

Journal: International journal of clinical practice

VOLUME: 61

Page Numbers: 1091-111

Journal Abbreviation: Int. J. Clin. Pract.

ISSN: 1368-5031

DAY: 30

MONTH: 05

YEAR: 2007

Times to pain relief and pain freedom with rizatriptan 10 mg and other oral triptans. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9712381

Times to pain relief and pain freedom with rizatriptan 10 mg and other oral triptans. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Times to pain relief and pain freedom with rizatriptan 10 mg and other oral triptans. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Times to pain relief and pain freedom with rizatriptan 10 mg and other oral triptans.

AFFILIATION: Outcomes Research and Management, Merck & Co., Inc., West Point, PA 19486, USA. daisy_ng_mak@merck.com

Country: England

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Int J Clin Pract

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Times to pain relief and pain freedom with rizatriptan 10 mg and other oral triptans Related Publications

• Atrial fibrillation in patients after cardiovascular surgery : incidence, risk factors, preventive and therapeutic strategies.
• Comparison of human papillomavirus distribution in cytologic subgroups of low-grade squamous intraepithelial lesion.
• Distribution of azithromycin by community health volunteers in ghana.
• Fe L-edge X-ray absorption spectroscopy of low-spin heme relative to non-heme Fe complexes: delocalization of Fe d-electrons into the porphyrin ligand.
• Fe L-edge XAS studies of K4[Fe(CN)6] and K3[Fe(CN)6]: a direct probe of back-bonding.
• Group and organizational involvement among persons with psychiatric disabilities in supported housing.
• Identification of the peroxy adduct in multicopper oxidases by a combination of computational chemistry and extended X-ray absorption fine-structure measurements.
• Inhibiting the renin-angiotensin system in myocardial infarction and heart failure: lessons from SAVE, VALIANT and CHARM, and other clinical trials.
• Intramolecular single-turnover reaction in a cytochrome C oxidase model bearing a Tyr244 mimic.
• Kinetic and spectroscopic studies of N694C lipoxygenase: a probe of the substrate activation mechanism of a nonheme ferric enzyme.
• Mad3p, a pseudosubstrate inhibitor of APCCdc20 in the spindle assembly checkpoint.
• Mitral regurgitation in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: prognostic significance and relation to ventricular size and function.
• Physician follow-up and provider continuity are associated with long-term medication adherence: a study of the dynamics of statin use.
• Predictors of stroke in high-risk patients after acute myocardial infarction: insights from the VALIANT Trial.
• Radioimaging of light chain amyloid with a fibril-reactive monoclonal antibody.
• Randomized, double-masked clinical trial evaluating corneal endothelial cell loss after cataract extraction and intraocular lens implantation: Fluid-based system versus ultrasound phacoemulsification.
• Spectroscopic and electronic structure studies of the role of active site interactions in the decarboxylation reaction of alpha-keto acid-dependent dioxygenases.
• Spectroscopic and electronic structure study of the enzyme-substrate complex of intradiol dioxygenases: substrate activation by a high-spin ferric non-heme iron site.
• Spectroscopic methods in bioinorganic chemistry: blue to green to red copper sites.
• Spectroscopic, computational, and kinetic studies of the mu4-sulfide-bridged tetranuclear CuZ cluster in N2O reductase: pH effect on the edge ligand and its contribution to reactivity.
• Sulfur K-edge X-ray absorption spectroscopy as a probe of ligand-metal bond covalency: metal vs ligand oxidation in copper and nickel dithiolene complexes.
• Sulfur K-edge XAS and DFT studies on NiII complexes with oxidized thiolate ligands: implications for the roles of oxidized thiolates in the active sites of Fe and Co nitrile hydratase.
• The children's computerized physical activity reporter: children as partners in the design and usability evaluation of an application for self-reporting physical activity.
• The impact of psychiatric comorbidity on general hospital length of stay.
• The importance of being discrete: life always wins on the surface.
• The two-state issue in the mixed-valence binuclear CuA center in cytochrome C oxidase and N2O reductase.
• Transit of hormonal and EGF receptor-dependent signals through cholesterol-rich membranes.
• What is orofacial fatigue and how does it affect function for swallowing and speech?
• What's new in trichiasis surgery?
• X-ray absorption edge spectroscopy and computational studies on LCuO2 species: Superoxide-Cu(II) versus peroxide-Cu(III) bonding.